Patentando ADN (Patenting DNA)
Carlos Augusto Conde Gutierrez
Universidad Externado de Colombia
June 27, 2011
Revista la Propiedad Inmaterial, No. 15, p. 47, November 2011
Patent systems in developed countries have made different interpretation or created new standards to embrace sequences of DNA as a patentable entity, regardless of the fact that in theory DNA did not fulfill requirements of patents (novelty, inventive step and industrial application (utility), and patent subject matter). This approach benefits R&D in the biotechnology industry. However, patents also represent a threat in R&D. This article studies both how patent systems in Europe adopted sequences of DNA and how patents could affect R&D in biotechnology.
Note: Downloadable document is in Spanish.
Number of Pages in PDF File: 13
Keywords: sequence of DNA, patents, novelty, inventive step, industrial application, patent subject matter, ownership, R&D, Europe, licensing, tragedy of commons, tragedy of anticommonsAccepted Paper Series
Date posted: November 30, 2011
© 2013 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo4 in 0.563 seconds